United States · How much has Nuclea Biotechnologies raised?
Nuclea Biotechnologies has raised $28M across 9 rounds since 2009.
2010201120122013
$8.9MVenture$425KDebt$3.0MSeries B$3.4MSeries B$3.4MSeries B$1.9MVenture$5.0MSeries C$1.1MSeed
United States · Seed startup
Who invested in Nuclea Biotechnologies
9 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Nuclea Biotechnologies and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$28Mraised across 9 rounds since 2009, from 9 sources
$8.9MVenture$5.0MSeries C
- Latest round
- Seed, $1.1MFeb 2013
- Biggest round
- $8.9MVenture · Jun 2009
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $8.9M Jun 2009
- Biggest round
- $8.9M Venture · Jun 2009
- Usual gap between rounds
- 4 months the median of 7
The rounds
- Feb 2013Seed$1.1M
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Feb 2013
- Aug 2012Series C$5.0M
No investor was named in the report.
Reported by masshightech.comSEC filing: $5.0M sold, first sale Jul 2012
- May 2012Venture$555K
No investor was named in the report.
Reported by masshightech.comSEC filing: $555K sold, first sale Apr 2012
- Apr 2012Venture$1.9M
No investor was named in the report.
Reported by masshightech.comSEC filing: $1.9M sold, first sale Mar 2012
- Feb 2012Series B$3.4M
No investor was named in the report.
Reported by masshightech.comSEC filing: $1.9M sold, first sale Mar 2012
- Oct 2011Series B$3.4M
No investor was named in the report.
Reported by masshightech.comSEC filing: $3.0M sold, first sale Aug 2011
- Aug 2011Series B$3.0M
No investor was named in the report.
Reported by masshightech.comSEC filing: $3.0M sold, first sale Aug 2011
- Dec 2010Debt$425K
No investor was named in the report.
From a historical funding recordSEC filing: $425K sold, first sale Nov 2010
- Jun 2009Venture$8.9M
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Jun 2009
Funding filed with regulators
Nuclea Biotechnologies filed 7 raises, $21M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Feb 2013$1.1MSEC Form D
- Jul 2012$5.0MSEC Form D
- Apr 2012$555KSEC Form D
- Mar 2012$1.9MSEC Form D
- Aug 2011$3.0MSEC Form D
- Nov 2010$425KSEC Form D
- Jun 2009$8.9MSEC Form D
Founders and team
From the SEC filings it signed: 3 on the team.
- Patrick J. MuracaExecutive Officer, Directori
- Paula J. EvansExecutive Officeri
- Robert J. PierceExecutive Officeri
On the board, as filediCharles P. StetsonRichard R. VietorWilliam R. Harman
Quick answers about Nuclea Biotechnologies
When did Nuclea Biotechnologies last raise?
Nuclea Biotechnologies's most recent round was a Seed of $1.1M in Feb 2013.
What was Nuclea Biotechnologies's biggest round?
Nuclea Biotechnologies's largest round on record is $8.9M (Venture), in Jun 2009.
What stage is Nuclea Biotechnologies at?
Nuclea Biotechnologies's latest named round is a Seed, in Feb 2013.
Where is Nuclea Biotechnologies based?
Nuclea Biotechnologies is based in the United States.
Companies like Nuclea Biotechnologies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.